IRIS UniCatt

Tortora, Giampaolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.651
AS - Asia 7.536
EU - Europa 5.143
SA - Sud America 1.621
AF - Africa 224
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.221
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.322
SG - Singapore 3.213
IT - Italia 1.491
CN - Cina 1.383
BR - Brasile 1.336
VN - Vietnam 1.010
SE - Svezia 917
DE - Germania 573
FR - Francia 543
IN - India 463
GB - Regno Unito 294
BD - Bangladesh 273
IE - Irlanda 241
FI - Finlandia 229
PL - Polonia 220
ID - Indonesia 212
HK - Hong Kong 207
JP - Giappone 199
CA - Canada 169
RU - Federazione Russa 123
NL - Olanda 120
AR - Argentina 104
MX - Messico 95
IQ - Iraq 87
KR - Corea 80
TR - Turchia 76
ES - Italia 69
AT - Austria 68
ZA - Sudafrica 67
EC - Ecuador 62
PK - Pakistan 45
UA - Ucraina 45
CI - Costa d'Avorio 42
IR - Iran 37
SA - Arabia Saudita 37
AU - Australia 34
BE - Belgio 30
UZ - Uzbekistan 30
CO - Colombia 29
CZ - Repubblica Ceca 29
VE - Venezuela 28
PH - Filippine 27
LT - Lituania 23
CH - Svizzera 20
EG - Egitto 20
JO - Giordania 20
CL - Cile 19
KE - Kenya 19
MA - Marocco 19
AE - Emirati Arabi Uniti 16
RO - Romania 15
IL - Israele 14
DZ - Algeria 13
PY - Paraguay 13
TW - Taiwan 13
TN - Tunisia 12
AZ - Azerbaigian 11
GR - Grecia 11
JM - Giamaica 11
MY - Malesia 11
KZ - Kazakistan 10
PE - Perù 10
PT - Portogallo 10
UY - Uruguay 10
BO - Bolivia 9
CR - Costa Rica 9
NP - Nepal 9
TH - Thailandia 9
AL - Albania 8
LV - Lettonia 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
BY - Bielorussia 7
HN - Honduras 7
HU - Ungheria 7
LB - Libano 7
NI - Nicaragua 7
RS - Serbia 7
CY - Cipro 6
DO - Repubblica Dominicana 6
NZ - Nuova Zelanda 6
PA - Panama 6
ET - Etiopia 5
LU - Lussemburgo 5
NG - Nigeria 5
SN - Senegal 5
GE - Georgia 4
MD - Moldavia 4
MM - Myanmar 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BJ - Benin 3
EU - Europa 3
GT - Guatemala 3
HR - Croazia 3
OM - Oman 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
Totale 23.178
Salva come PNG Salva come JPEG
Città #
Singapore 1.884
Ashburn 1.427
San Jose 883
Chandler 685
Rome 414
Ho Chi Minh City 346
Beijing 326
New York 282
Hanoi 259
Los Angeles 250
Dublin 234
Hyderabad 232
Hefei 222
Warsaw 198
Lauterbourg 194
Council Bluffs 191
Hong Kong 191
Tokyo 188
Milan 186
The Dalles 174
Frankfurt am Main 168
Fairfield 167
Jakarta 161
Chicago 151
São Paulo 138
Munich 133
Helsinki 131
Wilmington 110
Houston 109
Princeton 103
Boston 93
Seattle 90
Dallas 86
St Louis 79
Santa Clara 77
San Mateo 76
Seoul 75
Boardman 71
Buffalo 68
Orem 68
London 67
Moscow 66
Kent 64
Woodbridge 59
Nuremberg 57
Marseille 56
Cambridge 54
Denver 52
Cattolica 50
Turku 50
Da Nang 49
Toronto 48
Brooklyn 45
Lappeenranta 45
Atlanta 44
Chennai 44
Montreal 44
Paris 44
Abidjan 42
Düsseldorf 42
Johannesburg 41
Stockholm 41
Ann Arbor 40
Haiphong 40
Vienna 39
Mexico City 37
Rio de Janeiro 37
Amsterdam 36
Bremen 33
Phoenix 33
North Bergen 32
Baghdad 31
Poplar 31
Curitiba 30
Naples 29
Brussels 28
Manchester 28
Tashkent 26
Dhaka 25
Mumbai 25
Shanghai 25
Matera 24
Nanjing 24
Salt Lake City 24
Washington 24
Bexley 23
Guangzhou 23
Guayaquil 23
Belo Horizonte 22
Dearborn 22
Hải Dương 22
Augusta 21
Goiânia 21
Amman 20
Falkenstein 20
Florence 20
Brno 19
Campinas 19
Porto Alegre 19
Portsmouth 19
Totale 13.038
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 616
Pembrolizumab as first-line treatment for metastatic uveal melanoma 347
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 322
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 321
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 310
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 293
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 251
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 225
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 224
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 209
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 198
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 198
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 196
Gut microbiome, big data and machine learning to promote precision medicine for cancer 192
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 188
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 185
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 183
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 180
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 176
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 174
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 172
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 169
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 167
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 167
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 166
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 163
Management of single pulmonary metastases from colorectal cancer: State of the art 161
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 160
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 160
Contemporary Analysis of cardiac Tamponade Etiologies, Treatments, and Outcomes: the CATEO Study 159
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 156
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 155
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial 155
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 155
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 155
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 154
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 154
Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: A systematic review and meta-analysis. 151
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 151
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 147
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 147
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 147
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 146
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 145
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 144
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 141
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 139
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 138
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 138
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 138
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 137
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 137
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 135
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 135
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 132
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 132
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 131
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 131
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 131
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 131
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis 131
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 130
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 129
Skin cancer triage and management during COVID-19 pandemic. 129
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 127
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 127
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 127
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 127
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 127
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 126
Biomarkers of response to advanced prostate cancer therapy 125
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 124
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 124
Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new? 123
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 123
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 123
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 122
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 122
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial 121
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 119
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 119
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 119
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 119
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 118
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 118
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 118
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 115
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 115
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 115
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers 115
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 114
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 114
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations 114
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 114
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response 114
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 113
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 110
Post-traumatic growth in oncological patients during the COVID-19 pandemic 110
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 110
Totale 15.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/20221.056 123 40 26 111 44 38 19 134 50 35 225 211
2022/20232.290 327 288 166 313 127 253 139 164 227 82 100 104
2023/20242.118 59 321 81 88 85 201 366 321 45 82 185 284
2024/20254.517 96 84 319 158 273 153 269 154 579 660 906 866
2025/202612.536 1.414 507 824 1.760 1.944 567 1.914 654 824 782 655 691
Totale 23.629